Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,410
datasets available to search
ShareScore release 0.9.0
Dataset results
6,410 results for “results”
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Romania
<div> <p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Romania. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Institute of Hygiene and Veterinary Public Health</p> <p>VMPR_2022 – Institute of Hygiene and Veterinary Public Health</p> <p>VMPR_2021 – Institute of Hygiene and Veterinary Public Health</p> <p>VMPR_2020 – Institute of Hygiene and Veterinary Public Health</p> <p>VMPR_2019 – Institute of Hygiene and Veterinary Public Health</p> <p>VMPR_2018 – Institute of Hygiene and Veterinary Public Health</p> <p>VMPR_2017 – Institute of Hygiene and Veterinary Public Health</p> </div>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - France
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of France. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – French Agency for Food, Environmental and Occupational Health & Safety</p> <p>VMPR_2022 – French Agency for Food, Environmental and Occupational Health & Safety</p> <p>VMPR_2021 – French Agency for Food, Environmental and Occupational Health & Safety; Joint Service of the Laboratories of the<br>Ministry of Economy, Finance and Industry (DGCCRF and DGDDI)</p> <p>VMPR_2020 – French Agency for Food, Environmental and Occupational Health & Safety; Joint Service of the Laboratories of the<br>Ministry of Economy, Finance and Industry (DGCCRF and DGDDI)</p> <p>VMPR_2019 – French Agency for Food, Environmental and Occupational Health & Safety</p> <p>VMPR_2018 – French Agency for Food, Environmental and Occupational Health & Safety</p> <p>VMPR_2017 – French Agency for Food, Environmental and Occupational Health & Safety</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Denmark
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Denmark. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – National Food Institute - Technical University of Denmark</p> <p>VMPR_2022 – National Food Institute - Technical University of Denmark</p> <p>VMPR_2021 – National Food Institute - Technical University of Denmark</p> <p>VMPR_2020 – National Food Institute - Technical University of Denmark</p> <p>VMPR_2019 – National Food Institute - Technical University of Denmark</p> <p>VMPR_2018 – National Food Institute - Technical University of Denmark</p> <p>VMPR_2017 – National Food Institute - Technical University of Denmark</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Belgium
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Belgium. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Federal Agency for the Safety of the Food Chain</p> <p>VMPR_2022 – Federal Agency for the Safety of the Food Chain</p> <p>VMPR_2021 – Federal Agency for the Safety of the Food Chain</p> <p>VMPR_2020 – Federal Agency for the Safety of the Food Chain</p> <p>VMPR_2019 – Federal Agency for the Safety of the Food Chain</p> <p>VMPR_2018 – Federal Agency for the Safety of the Food Chain</p> <p>VMPR_2017 – Federal Agency for the Safety of the Food Chain</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - The Czech Republic
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of The Czech Republic. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State Veterinary Administration - Ministry of Agriculture</p> <p>VMPR_2022 – State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2021 – State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2020 – State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2019 – State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2018 – State Veterinary Administration - Ministry of Agriculture; National Institute of Public Health in Prague, Center for Health, Nutrition and Food</p> <p>VMPR_2017 – State Veterinary Administration - Ministry of Agriculture</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Bulgaria
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Bulgaria. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2022 – Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2021 – Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2020 – Central Laboratory for Veterinary Sanitary Expertise and Ecology within the Bulgarian Food Safety Agency</p> <p>VMPR_2019 – Risk Assessment Center on Food Chain</p> <p>VMPR_2018 – Bulgarian Food Safety Agency</p> <p>VMPR_2017 – Bulgarian Food Safety Agency</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Hungary
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Hungary. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – National Food Chain Safety Office</p> <p>VMPR_2022 – National Food Chain Safety Office</p> <p>VMPR_2021 – National Food Chain Safety Office</p> <p>VMPR_2020 – National Food Chain Safety Office</p> <p>VMPR_2019 – National Food Chain Safety Office</p> <p>VMPR_2018 – National Food Chain Safety Office</p> <p>VMPR_2017 – National Food Chain Safety Office</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Sweden
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Sweden. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – National Food Agency</p> <p>VMPR_2022 – National Food Agency</p> <p>VMPR_2021 – National Food Agency</p> <p>VMPR_2020 – National Food Agency</p> <p>VMPR_2019 – National Food Agency</p> <p>VMPR_2018 – National Food Agency</p> <p>VMPR_2017 – National Food Agency</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Lithuania
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Lithuania. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2022 – National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2021 – National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2020 – National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2019 – National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2018 – National Food and Veterinary Risk Assessment Institute</p> <p>VMPR_2017 – National Food and Veterinary Risk Assessment Institute</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Spain
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Spain. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Spanish Agency for Food Safety and Nutrition; Ministry of Health</p> <p>VMPR_2022 – Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2021 – Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2020 – Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2019 – Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2018 – Spanish Agency for Food Safety and Nutrition</p> <p>VMPR_2017 – Spanish Agency for Food Safety and Nutrition; Ministry of Agriculture and Fisheries, Food and Environment</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Germany
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Germany. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2022 – Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2021 – Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2020 – Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2019 – Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2018 – Federal Office of Consumer Protection and Food Safety</p> <p>VMPR_2017 – Federal Office of Consumer Protection and Food Safety</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - United Kingdom in respect of Northern Ireland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of United Kingdom in respect of Northern Ireland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p>For 2021 and 2022 the only United Kingdom data that were reported to EFSA were from Northern Ireland. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Irelandfrom the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the WindsorFramework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee establishedby the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the EuropeanUnion and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p.87) in conjunction withsection 24 of Annex 2 to that Framework, for the purposes of this Regulation, references to Member States include theUnited Kingdom in respect of Northern Ireland.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Department of Agriculture, Environment and Rural Affairs</p> <p>VMPR_2022 – Department of Agriculture, Environment and Rural Affairs</p> <p>VMPR_2021 – Department of Agriculture, Environment and Rural Affairs</p>
Database Search Results for Resource Management in Converged Optical and MillimeterWave Radio Networks Review
<p><strong>Paper Selection Procedure</strong></p> <p>In order to conduct the survey titled "Resource Management in Converged Optical and MillimeterWave Radio Networks: A Review", the authors reviewed works published in the literature with a focus on those that cover most of the identified optimization requirements for converged optical fronthaul and mmWave wireless access networks. The research method is based on the research steps given in "The PRISMA 2020 statement"[1]. The selection procedure is also illustrated in "Database Search Flow Chart.png" figure.</p> <p>The first step was the selection of the papers. We completed this step by making database searches in the ACM, Elsevier (Science Direct), IEEE, IET, MDPI, Optical Society (OSA), Springer, Taylor & Francis, and Wiley online library databases with keywords ``resource allocation AND converged mmWave fiber wireless (FiWi)'', ``resource management AND converged mmWave fiber wireless (FiWi)'', and ``resource allocation AND converged fiber wireless (FiWi)''. The searches in all databases were completed in May 2021. The resulting collection was screened, to exclude non-scientific texts, book chapters, out of context papers, and survey papers. The remaining 189 papers found in our database search are provided in the excel file titled "FiWi Resource Allocation Database Search.xlsx".</p> <p>Among these papers, our selection criteria was created to present the works that are most relevant to the target network architecture, providing novel implementation solutions to the requirements of the optimization objective. The criteria selected for our eligibility step can be summarized as follows:</p> <ul> <li>The study provided a sound research approach and published after a scholarly review process;</li> <li>The study had a resource management optimization objective for mmWave networks;</li> <li>The study explained the system model and proposed a well-defined optimization algorithm;</li> <li>The effects of the algorithm on a performance metric was reported and the different aspects of the performance metric was analyzed with different evaluation criteria.</li> </ul> <p>This review is limited to the focus scope on converged optical and mmWave radio network solutions and by the databases taken into consideration. The prioritization of the works that address a well-defined optimization algorithm led to the omission of relevant papers. We did not include works that do not clearly define a resource management objective, i.e., a study that focuses on the the hardware implementation aspects of optical and mmWave radio networks with no resource management perspective. We manually excluded all studies that do not match these criteria with a simple scoring system, in which a point is deducted from an eligible paper for each missing criterion. The initial screening process and the data collection steps were carried out by the first author and the final inclusion decision was made by all the reviewers for the studies with the highest scores. After this screening process, we identified 37 papers that focused on at least one of the resource management objectives of throughput maximization, delay minimization, energy-efficiency, and virtualized resource allocation. The papers that have joint objectives are classified under their main optimization focus of that paper. The list of the selected papers are provided in "FiWi Resource Allocation Papers Selected for Review.xlsx" file. Our target in this review is to understand the recent optimization techniques used in resource allocation for converged optical fronthaul and radio mmWave access network implementations, therefore we focused our search to the works completed in the last five years (between 2016 and 2021), and approximately 95% of the selected papers fit under this category.</p> <p><strong>Overview of the data collected from selected papers</strong></p> <p>In this section, we provide answers to the three following questions with the data collected from the eligible studies:</p> <ul> <li>Question 1: Which algorithms are used more often in performance optimization in converged mmWave networks?</li> <li>Question 2: Which performance metrics are determined to show that the optimization method achieves the objective?</li> <li>Question 3: Which criteria are used to evaluate the solution method?</li> </ul> <p>Regarding the first question, the figure titled "Distribution of Optimization Algorithms in Selected Papers" shows the distribution of the optimization algorithms used by the selected papers. The distribution of the main performance metrics according to the resource optimization objectives is given in Table 1 (Distribution of Evaluation Criteria) and the evaluation criteria to test the performances of the selected papers are grouped in Table 2 (Distribution of Main Performance Metrics Depending on Optimization Objectives), which shows how many times each criterion is used together with how many of the resource management objectives use these criterion.</p> <p><strong>References: </strong></p> <p>[1] Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.;Brennan, S.E.; Chou, R.; Glanville, J.; Grimshaw, J.M.; Hróbjartsson, A.; Lalu, M.M.; Li, T.; Loder, E.W.; Mayo-Wilson, E.;McDonald, S.; McGuinness, L.A.; Stewart, L.A.; Thomas, J.; Tricco, A.C.; Welch, V.A.; Whiting, P.; Moher, D. The PRISMA 2020statement: an updated guideline for reporting systematic reviews.Systematic Reviews2021,10. doi:10.1186/s13643-021-01626-4.</p>
Survey results - Implementation of interprofessional collaboration
<p>This dataset contains the variables, values and results for a survey run among the students of the pilot course "Interprofessionelle Gesundheitsversorgung - online" to determine effects of the course on the implementation of interprofessional collaboration in students' professional environment.</p> <p>The dataset is licensed under a Creative Commons Attribution 4.0 International (<a href="https://creativecommons.org/licenses/by/4.0/legalcode">CC BY 4.0</a>) license.</p>
First Results on Wake Detection in SAR Images by Deep Learning
<p>Supplementary Materials of the paper "First Results on Wake Detection in SAR Images by Deep Learning" published on MDPI - Remote Sensing</p>
IUCLID templates for PPP Risk Assessment - Template 7.2 - Template for presenting the results of the OECD 106 evaluators checklist
<p>This word file contains the template for <strong>presenting the results of the OECD 106 evaluators checklist</strong>. The template has been draft based on the Technical report on the outcome of the pesticides peer review meeting on the OECD 106 evaluators checklist (EFSA, 2017).<br> The filled-in template shall be pasted in the "<strong>Any other information on results incl. tables</strong> " field of IUCLID document “<strong>Adsorption and desorption in soil</strong>”<strong> </strong>endpoint study record (Section 7.1.3.1 of active substance dataset).</p>
Which journal characteristics are crucial for scientists when selecting journals for their publications? Results tables of an online survey
<p>As part of the BMBF-funded project "B!SON - Bibliometric and Semantic Open Access Recommender Network", an online survey was conducted among scientists using SoSci Survey (Leiner, 2019). The aim of the survey was to determine the importance of various characteristics of scientific journals in the decision for a publication venue by scientists. The characteristics were determined by analysis of other recommender systems, literature research and discussion with scientists. The data published here are based on 884 completed questionnaires (only questionnaires in which at least 90% of the questions had been answered were included in the analysis).</p> <p>In the questionnaire, a distinction was made between those characteristics that scientists would like to use to limit the selection of eligible journals from the outset (table "B!SON_Survey_Filter_Criteria_EN") and those that scientists need for their final decision from a list of recommended journals ("B!SON_Survey_Journal_Selection_EN"). For each journal property, the respondents could choose between the categories of a 5-point Likert scale: "not at all important - not very important - somewhat important - very important - extremely important". If the scientists were not able to evaluate a characteristic, they could also select "I can't say". </p> <p>In the two tables of results, the approval percentage and the rank based on it are listed for all journal properties queried in the respective part of the survey. The approval percentage is calculated from the percentage of people who rated the respective property as "very important" or "extremely important". Approval rate and rank are presented across all respondents (overall column), as well as within the 4 science disciplines by DFG (Natural Sciences, Engineering Sciences, Life Sciences, Humanities and Social Sciences) and the category "Other Sciences".</p> <p>Both tables can be sorted by approval rate and rank per scientific discipline or across disciplines.</p> <p>Note on the use of the HTML files: These can be downloaded via the download button and then opened and viewed with any web browser.</p> <p>A German version of the results tables is available under <a href="https://doi.org/10.5281/zenodo.5412197">https://doi.org/10.5281/zenodo.5412197</a>.</p>
Information and results obtained from IoT Platform in Alba Iulia Pilot
<p> </p> <p> The IoT platform allows the geolocation of the container, as well as manage the information of the filling level and traceability of trucks. The eco driving application on board of the truck sends the data from the truck (location, speed, RPM and engine load) t o the IoT platform where it is stored. At the same time sound alarms are emitted when driver excess the ecodriving parameters in the Android application. Besides this, the application receives from the IoT platform the position of the containers that must be collected.</p> <p>In this way the driver can see the position, order of collection of the containers and pathway to collect them, as explained above.<br> The IoT platform receives the information of the labels dispensed from the smart containers. The score of the characterized bags were registered in the platform as explained in the next section. </p> <p>Attached the different data sets generated during the project.</p> <p>For general info, follow the link: https://plasticircle.eu/home/</p>
Information and results obtained from IoT Platform in Valencia Pilot
<p> The IoT platform allows the geolocation of the container, as well as manage the information of the filling level and traceability of trucks. The eco driving application on board of the truck sends the data from the truck (location, speed, RPM and engine load) t o the IoT platform where it is stored. At the same time sound alarms are emitted when driver excess the ecodriving parameters in the Android application. Besides this, the application receives from the IoT platform the position of the containers that must be collected.</p> <p>In this way the driver can see the position, order of collection of the containers and pathway to collect them, as explained above.<br> The IoT platform receives the information of the labels dispensed from the smart containers. The score of the characterized bags were registered in the platform as explained in the next section. </p> <p>Attached the different data sets generated during the project.</p> <p>For general info, follow the link: https://plasticircle.eu/home/</p> <p> </p>
TSE results complementing the European Union summary report on surveillance for the presence of transmissible spongiform encephalopathies (TSE) - the United Kingdom
<p>This dataset contains TSE surveillance results in cattle, sheep, goats, cervids and other species, and genotyping in sheep, pursuant to Regulation (EC) 999/2001.</p> <p>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION: TSE_2020_UK: Animal and Plant Health Agency (APHA)</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.